Key Figures
5
Plants
manufacturing sterile forms, cephalosporins, penicillins, dry and liquid forms, soft capsules and inhalation powders.
600
employees
where 50% are managers
30
million
drug boxes are manufactured
71
million de tnd
of turnover
20
% of development
over the last three years
150
million
invested during the last 3 years
1
er manufacture
of cardiovascular drugs and generic antibiotics in Tunisia
ISO
26000
1st Tunisian Pharmaceutical Laboratory adherent to the ISO 26000 standard, related to social responsibility and sustainable development